Silchester International Investors LLP Pfizer Inc Transaction History

Silchester International Investors LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $4.01 Million - $4.57 Million	-104,288 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $1.99 Million - $2.41 Million	57,719 Added 123.94%	104,288 $4.6 Million
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $183,929 - $196,087	5,577 Added 13.61%	46,569 $1.69 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $352,669 - $409,145	11,052 Added 36.91%	40,992 $1.46 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $995,804 - $1.06 Million	29,940	29,940 $1.08 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Silchester International Investors LLP, based on Form 13F filings with the SEC.

Stay updated on Silchester International Investors LLP with notifications on news.